In vitro anti-Toxoplasma gondii efficacy of synthesised benzyltriazole derivatives
Toxoplasma gondii, an obligate intracellular parasite, is the aetiological agent of toxoplasmosis, a disease that affects approximately 25% – 30% of the world’s population. At present, no safe and effective vaccine exists for the prevention of toxoplasmosis. Current treatment options for toxoplasmos...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2021-06-01
|
Series: | Onderstepoort Journal of Veterinary Research |
Subjects: | |
Online Access: | https://ojvr.org/index.php/ojvr/article/view/1898 |